30 Day Psychedelic Pharmacology Podcast - Day 14 Microdosing episode artwork

EPISODE · Jan 30, 2025 · 13 MIN

30 Day Psychedelic Pharmacology Podcast - Day 14 Microdosing

from Cannabinoid and Psychedelic Pharmacology and Drug Development

This podcast episode explores microdosing psychedelics, focusing on the science behind how these substances interact with brain receptors, particularly the 5HT2A receptor. The hosts discuss how microdosing differs from full doses, with the goal of achieving subtle effects without triggering full psychedelic experiences. They examine current research, potential benefits, and risks, while emphasizing that scientific evidence is still limited and more rigorous studies are needed. The conversation also covers broader implications for mental health treatment and society, concluding with advice about the importance of informed, cautious approaches to microdosing.

Episode metadata supplied by the publisher feed · Published Jan 30, 2025

Embed this episode

NOW PLAYING

30 Day Psychedelic Pharmacology Podcast - Day 14 Microdosing

0:00 13:50

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Cannabinoid and Psychedelic Pharmacology and Drug Development?

This episode is 13 minutes long.

When was this Cannabinoid and Psychedelic Pharmacology and Drug Development episode published?

This episode was published on January 30, 2025.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Cannabinoid and Psychedelic Pharmacology and Drug Development episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!